Remarks on Requiring List Prices in Drug Ads | HHS.gov

Remarks on Requiring List Prices in Drug Ads | HHS.gov

Remarks on Requiring List Prices in Drug Ads Alex M. Azar II Press   "If there’s one thing I want you to remember about the action we took today, it’s that requiring drug companies to level with American patients about their prices is about working toward a system where the patient—not the insurer, not the drug company, but the patient—is the one in control of your healthcare."

Read More